3sbio Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares 3sbio Inc with three other companies in this sector in China: Sunflower Pharmaceutical Group Co Ltd (2018 sales of 4.47 billion Chinese Renmimbi [US$626.94 million] of which 96% was Medicine), Renhe Pharmacy Company Limited (4.40 billion Chinese Renmimbi [US$617.33 million] of which 99% was Medicine), and Shenzhen Salubris Pharmaceuticals Co Ltd (4.65 billion Chinese Renmimbi [US$652.24 million] of which 100% was Pharmaceutical Manufacturing).

Sales Analysis. 3sbio Inc reported sales of 4.58 billion Chinese Renmimbi (US$642.70 million) for the year ending December of 2018. This represents an increase of 22.7% versus 2017, when the company's sales were 3.73 billion Chinese Renmimbi. Sales at 3sbio Inc have increased during each of the previous five years (and since 2013, sales have increased a total of 424%).